Literature DB >> 8628542

Field of dreamers and dreamed-up fields: functional and fake perimetry.

J C Thompson1, G S Kosmorsky, B D Ellis.   

Abstract

PURPOSE: Hysterical and malingering patients can manifest visual field defects on perimetry (visual field testing), including defects suggestive of true visual pathway pathology. It has been shown that control subjects can easily imitate some pathologic defects with automated, computed perimetry. The authors sought to determine whether subjects could imitate the same pathologic defect with manual and automated perimetry.
METHOD: Six subjects posed as patients with neurologic problems. They had manual perimetry with both an experienced and inexperienced technician followed by automated perimetry. They were later interviewed about the methods of the technicians and the difficulty of the exercise.
RESULTS: Four of six subjects easily imitated the assigned defects with both technicians on manual perimetry and with automated perimetry. These included quadrantic, altitudinal, hemianopic, and enlarged blind-spot defects. Two subjects who were assigned cecocentral and paracentral scotomas instead produced enlarged blind spots by manual perimetry and defects suggestive of chiasmal pathology by automated perimetry. Paradoxically, some subjects found that experienced technicians were easier to fool than inexperienced technicians because of the systematic way in which experienced technicians defined defects.
CONCLUSIONS: With minimal coaching, some subjects can imitate visual fields with enlarged blind spots, quadrantic, hemianopic, and altitudinal defects with ease and reproducibility by both automated and manual perimetry. Cecocentral and paracentral scotomas are harder to imitate but may be mistaken as representing chiasmal pathology. Paradoxically, experienced technicians may not be better at detecting hysterical or malingering individuals.

Entities:  

Mesh:

Year:  1996        PMID: 8628542     DOI: 10.1016/s0161-6420(96)30751-3

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  12 in total

Review 1.  Non-organic visual loss.

Authors:  S Beatty
Journal:  Postgrad Med J       Date:  1999-04       Impact factor: 2.401

2.  Long term changes in the visual fields of patients with temporal lobe epilepsy using vigabatrin.

Authors:  P Hardus; W M Verduin; G Postma; J S Stilma; T T Berendschot; C W van Veelen
Journal:  Br J Ophthalmol       Date:  2000-07       Impact factor: 4.638

3.  Artefactual uniocular altitudinal visual field defect.

Authors:  V Kumar; U S Ramanathan; B Mushtaq; P Shah
Journal:  Br J Ophthalmol       Date:  2002-12       Impact factor: 4.638

4.  Diagnosis and management of functional visual deficits.

Authors:  Jacqueline A Leavitt
Journal:  Curr Treat Options Neurol       Date:  2006-01       Impact factor: 3.598

5.  [Testing and approach when non-organic visual loss is suspected].

Authors:  Anna Sophie Mursch-Edlmayr; D Mojon; M Bolz
Journal:  Ophthalmologe       Date:  2018-01       Impact factor: 1.059

6.  Malingering or simulation in ophthalmology-visual acuity.

Authors:  Ali Ihsan Incesu; Güngör Sobacı
Journal:  Int J Ophthalmol       Date:  2011-10-18       Impact factor: 1.779

7.  Functional Visual Loss.

Authors:  Kenneth S. Shindler; Steven L. Galetta; Nicholas J. Volpe
Journal:  Curr Treat Options Neurol       Date:  2004-01       Impact factor: 3.598

8.  Tests for malingering in ophthalmology.

Authors:  Ali Ihsan Incesu
Journal:  Int J Ophthalmol       Date:  2013-10-18       Impact factor: 1.779

9.  Using standardised patients to measure physicians' practice: validation study using audio recordings.

Authors:  Jeff Luck; John W Peabody
Journal:  BMJ       Date:  2002-09-28

Review 10.  Functional vision disorders in adults: a paradigm and nomenclature shift for ophthalmology.

Authors:  Subahari Raviskanthan; Sydney Wendt; Peter M Ugoh; Peter W Mortensen; Heather E Moss; Andrew G Lee
Journal:  Surv Ophthalmol       Date:  2021-03-15       Impact factor: 6.197

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.